Published :
Tables : 160
Figures : 30
Category : Healthcare
No. of Pages : 250
Report Code : HC-1278
Cardiac Monitoring and Cardiac Rhythm Management Devices Market is estimated to value over USD 32 billion by 2027 end and register a CAGR of over 4.8% during the forecast period 2020 to 2027. The surge of patients suffering from ailments such as heart failure and recurrent arrhythmias has contributed significantly to the cardiac rhythm management (CRM) devices market. This market has seen exponential growth due to technological progress, cardiac disorders, a greater awareness among patients and a rise in the untreated medical conditions in developing nations. But despite all the advancements, the market still encounters some hindrances such as the exorbitant costs, lack of insurance coverage alternatives and an inclination to choose drugs over treatment devices. All these factors are especially prevalent in developing nations. Having said that, the developments in the latest MRI-labeled devices, along with the growth in the economies of LAMEA and Asia-Pacific regions have been predicted to augment the growth of the industries involved in the manufacture of cardiac rhythm management and cardiac monitoring. Segmentation-wise, the market has been bifurcated into cardiac rhythm management and cardiac monitoring. These two segments have been divided into cardiac rhythm management devices and conventional monitoring devices. Here, the monitoring device has been categorised into event monitors, cardiac monitors, ECG, Holter monitors and ILR (implantable loop recorder). Cardiac rhythm management (CRM) has been classified into sub-segments which includes defibrillators, pacemakers and cardiac resynchronization devices. Electrocardiography (ECG) market has been anticipated to account for the largest segment in the forecast time frame, while ILR is predicted to be the fastest growing segment and pacemakers and defibrillators are widely used in the area of diagnostics. These are likely to exhibit robust growth in the next six years because they are, in fact, the most mature market. Cardiac telemetry and ECG data management are two such systems that are highly up to date and will demonstrate positive changes in the ambulatory and home health care services. The segmentation of the end users are home health care facilities, hospitals and ambulatory services. The ease of treatment and the affordability of the ambulatory and home health care facilities rank as some of the main factors in the substantial market growth. Key players in this market includes Life Watch, Philips Healthcare, Boston Scientific, GE healthcare, Nihon Kohden Corporation, Spacelabs Healthcare, Cardiac Science Corporation, Scottcare Corporation, Zoll Medical Corporation, Schiller,St. Jude Medical CardioNet, Welch Allyn, Ecardio Diagnostics, Mortara Instruments and Medtronic. Cardiac Monitoring and & Cardiac Rhythm Management Devices Market Segmentation: By Product Cardiac Rhythm Management Devices Cardiac Monitoring Devices By Product ECG Devices By Type Resting ECG Systems Stress ECG Systems Holter Monitors ECG Devices Market, By Lead Type Single-Lead ECG Leadwires 3–6 ECG Leadwires 12 ECG Leadwires Other ECG Leadwires Implantable Loop Recorders Cardiac Output Monitoring (COM) Devices By Type Minimally Invasive COM Devices Noninvasive COM Devices Event Monitors By Type Pre-Symptom (Memory Loop) Post-Symptom Event Monitor By Technology Autodetect Monitors Manual Event Monitor Mobile Cardiac Telemetry Monitoring (MCT/MCOT) Smart Wearable ECG Monitors Defibrillators Implantable Cardioverter Defibrillators Transvenous Implantable Cardioverter Defibrillators Biventricular ICDS/Cardiac Resynchronization Therapy Defibrillators Dual-Chamber ICDS Single-Chamber ICDS Subcutaneous Implantable Cardioverter Defibrillators External Defibrillators Automated External Defibrillators Fully Automated External Defibrillators Semi-Automated External Defibrillators Manual External Defibrillators Wearable Cardioverter Defibrillators Pacemakers By Implantability Implantable Pacemakers External Pacemaker By Type Dual-Chamber Pacemakers Single-Chamber Pacemakers By End User Hospitals Home and Ambulatory Care Settings Other End Users By Region North America Europe Asia Pacific Rest of the World FutureWise Key Takeaways: Growth prospects SWOT analysis Key trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the Cardiac Monitoring and & Cardiac Rhythm Management Devices Market market by product, by type, by end user and by region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East & Africa To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Profiling of companies to evaluate their market
The surge of patients suffering from ailments such as heart failure and recurrent arrhythmias has contributed significantly to the cardiac rhythm management (CRM) devices market. This market has seen exponential growth due to technological progress, cardiac disorders, a greater awareness among patients and a rise in the untreated medical conditions in developing nations. But despite all the advancements, the market still encounters some hindrances such as the exorbitant costs, lack of insurance coverage alternatives and an inclination to choose drugs over treatment devices. All these factors are especially prevalent in developing nations. Having said that, the developments in the latest MRI-labeled devices, along with the growth in the economies of LAMEA and Asia-Pacific regions have been predicted to augment the growth of the industries involved in the manufacture of cardiac rhythm management and cardiac monitoring.
Segmentation-wise, the market has been bifurcated into cardiac rhythm management and cardiac monitoring. These two segments have been divided into cardiac rhythm management devices and conventional monitoring devices. Here, the monitoring device has been categorised into event monitors, cardiac monitors, ECG, Holter monitors and ILR (implantable loop recorder). Cardiac rhythm management (CRM) has been classified into sub-segments which includes defibrillators, pacemakers and cardiac resynchronization devices.
Electrocardiography (ECG) market has been anticipated to account for the largest segment in the forecast time frame, while ILR is predicted to be the fastest growing segment and pacemakers and defibrillators are widely used in the area of diagnostics. These are likely to exhibit robust growth in the next six years because they are, in fact, the most mature market. Cardiac telemetry and ECG data management are two such systems that are highly up to date and will demonstrate positive changes in the ambulatory and home health care services.
The segmentation of the end users are home health care facilities, hospitals and ambulatory services. The ease of treatment and the affordability of the ambulatory and home health care facilities rank as some of the main factors in the substantial market growth.
Key players in this market includes Life Watch, Philips Healthcare, Boston Scientific, GE healthcare, Nihon Kohden Corporation, Spacelabs Healthcare, Cardiac Science Corporation, Scottcare Corporation, Zoll Medical Corporation, Schiller,St. Jude Medical CardioNet, Welch Allyn, Ecardio Diagnostics, Mortara Instruments and Medtronic.
Cardiac Monitoring and & Cardiac Rhythm Management Devices Market Segmentation:
By Product
By End User
By Region
FutureWise Key Takeaways:
Objectives of the Study:
1 Cardiac Monitoring Market: Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Markets Covered 1.4 Years Considered for the Study 1.5 Currency 1.6 Limitations 1.7 Stakeholders 2 Cardiac Monitoring Market: Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data From Primary Sources 2.1.2.2 Breakdown of Primaries 2.1.2.3 Key Industry Insights 2.2 Market Size Estimation 2.2.1 Bottom-Up Approach 2.2.2 Top-Down Approach 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions 3 Cardiac Monitoring Market: Executive Summary 4 Cardiac Monitoring Market: Premium Insights 4.1 Cardiac Monitoring and Cardiac Rhythm Management Devices Market Overview 4.2 Asia: Cardiac Monitoring Devices Market, By Product and Country, 2018 vs 2023 (USD Million) 4.3 Defibrillators Market, By Product 4.4 Cardiac Monitoring and Cardiac Rhythm Management Devices Market, By End User 5 Cardiac Monitoring Market: Overview 5.1 Introduction 5.2 Market Dynamics 5.2.1 Drivers 5.2.1.1 Increasing Incidence of Cardiovascular Diseases 5.2.1.2 Technological Advancements 5.2.2 Restraints 5.2.2.1 Price-Sensitive Market 5.2.2.2 Limited Reimbursements for Remote Cardiac Monitoring Devices 5.2.3 Opportunities 5.2.3.1 Rising Opportunities in Emerging Markets 5.2.3.2 Smart Wearable ECG Monitors 5.2.4 Challenges 5.2.4.1 Dearth of Skilled Professionals With Expertise in Electrocardiography and Cardiac Rhythm Management Devices 5.2.4.2 Frequent Product Recalls 6 CM and CRM Devices Market, By Product 6.1 Introduction 6.2 Cardiac Rhythm Management Devices 6.3 Cardiac Monitoring Devices 7 Cardiac Monitoring Devices Market, By Product 7.1 Introduction 7.2 ECG Devices 7.3 ECG Devices Market, By Type 7.3.1 Resting ECG Systems 7.3.2 Stress ECG Systems 7.3.3 Holter Monitors 7.4 ECG Devices Market, By Lead Type 7.4.1 Single-Lead ECG Leadwires 7.4.2 3–6 ECG Leadwires 7.4.3 12 ECG Leadwires 7.4.4 Other ECG Leadwires 7.5 Implantable Loop Recorders 7.6 Cardiac Output Monitoring (COM) Devices 7.6.1 COM Devices Market, By Type 7.6.1.1 Minimally Invasive COM Devices 7.6.1.2 Noninvasive COM Devices 7.7 Event Monitors 7.7.1 Event Monitors Market, By Type 7.7.1.1 Pre-Symptom (Memory Loop) 7.7.1.2 Post-Symptom Event Monitor 7.7.2 Event Monitors Market, By Technology 7.7.2.1 Autodetect Monitors 7.7.2.2 Manual Event Monitor 7.8 Mobile Cardiac Telemetry Monitoring (MCT/MCOT) 7.9 Smart Wearable ECG Monitors 8 Cardiac Monitoring Market: By Product 8.1 Introduction 8.2 Defibrillators 8.2.1 Implantable Cardioverter Defibrillators 8.2.1.1 Transvenous Implantable Cardioverter Defibrillators 8.2.1.1.1 Biventricular ICDS/Cardiac Resynchronization Therapy Defibrillators 8.2.1.1.2 Dual-Chamber ICDS 8.2.1.1.3 Single-Chamber ICDS 8.2.1.2 Subcutaneous Implantable Cardioverter Defibrillators 8.2.2 External Defibrillators 8.2.2.1 Automated External Defibrillators 8.2.2.1.1 Fully Automated External Defibrillators 8.2.2.1.2 Semi-Automated External Defibrillators 8.2.2.2 Manual External Defibrillators 8.2.2.3 Wearable Cardioverter Defibrillators 8.3 Pacemakers 8.3.1 Pacemakers Market, By Implantability 8.3.1.1 Implantable Pacemakers 8.3.1.2 External Pacemakers 8.3.2 Pacemakers Market, By Type 8.3.2.1 Dual-Chamber Pacemakers 8.3.2.2 Single-Chamber Pacemakers 9 Cardiac Monitoring and Cardiac Rhythm Management Devices Market, By End User 9.1 Introduction 9.2 Hospitals 9.3 Home and Ambulatory Care Settings 9.4 Other End Users 10 Cardiac Monitoring and Cardiac Rhythm Management Market, By Region 10.1 Introduction 10.2 North America 10.2.1 US 10.2.2 Canada 10.3 Europe 10.3.1 Germany 10.3.2 France 10.3.3 UK 10.3.4 Italy 10.3.5 Spain 10.3.6 Rest of Europe 10.4 Asia 10.4.1 Japan 10.4.2 China 10.4.3 India 10.4.4 Rest of Asia (RoA) 10.5 Rest of the World 11 Cardiac Monitoring Market: Competitive Landscape 11.1 Introduction 11.2 Competitive Situation and Trends 11.2.1 Product Launches and Approvals 11.2.2 Agreements, Partnerships, and Contracts 11.2.3 Mergers and Acquisitions 11.2.4 Expansions 12 Company Profiles 12.1 Medtronic 12.2 Abbott 12.3 Boston Scientific 12.4 GE Healthcare 12.5 Philips Healthcare 12.6 Biotronik 12.7 Cardiac Science (A Portfolio Company of the Aurora Capital Group) 12.8 Livanova 12.9 Hill-Rom Holdings 12.10 Schiller 12.11 Biotelemetry 12.12 Applied Cardiac System Chapter 13 Research Finding and Conclusion Chapter 14 Research Methodology Chapter 15 Research Data Source
1 Cardiac Monitoring Market: Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Markets Covered
1.4 Years Considered for the Study
1.5 Currency
1.6 Limitations
1.7 Stakeholders
2 Cardiac Monitoring Market: Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Breakdown of Primaries
2.1.2.3 Key Industry Insights
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Assumptions
3 Cardiac Monitoring Market: Executive Summary
4 Cardiac Monitoring Market: Premium Insights
4.1 Cardiac Monitoring and Cardiac Rhythm Management Devices Market Overview
4.2 Asia: Cardiac Monitoring Devices Market, By Product and Country, 2018 vs 2023 (USD Million)
4.3 Defibrillators Market, By Product
4.4 Cardiac Monitoring and Cardiac Rhythm Management Devices Market, By End User
5 Cardiac Monitoring Market: Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Incidence of Cardiovascular Diseases
5.2.1.2 Technological Advancements
5.2.2 Restraints
5.2.2.1 Price-Sensitive Market
5.2.2.2 Limited Reimbursements for Remote Cardiac Monitoring Devices
5.2.3 Opportunities
5.2.3.1 Rising Opportunities in Emerging Markets
5.2.3.2 Smart Wearable ECG Monitors
5.2.4 Challenges
5.2.4.1 Dearth of Skilled Professionals With Expertise in Electrocardiography and Cardiac Rhythm Management Devices
5.2.4.2 Frequent Product Recalls
6 CM and CRM Devices Market, By Product
6.1 Introduction
6.2 Cardiac Rhythm Management Devices
6.3 Cardiac Monitoring Devices
7 Cardiac Monitoring Devices Market, By Product
7.1 Introduction
7.2 ECG Devices
7.3 ECG Devices Market, By Type
7.3.1 Resting ECG Systems
7.3.2 Stress ECG Systems
7.3.3 Holter Monitors
7.4 ECG Devices Market, By Lead Type
7.4.1 Single-Lead ECG Leadwires
7.4.2 3–6 ECG Leadwires
7.4.3 12 ECG Leadwires
7.4.4 Other ECG Leadwires
7.5 Implantable Loop Recorders
7.6 Cardiac Output Monitoring (COM) Devices
7.6.1 COM Devices Market, By Type
7.6.1.1 Minimally Invasive COM Devices
7.6.1.2 Noninvasive COM Devices
7.7 Event Monitors
7.7.1 Event Monitors Market, By Type
7.7.1.1 Pre-Symptom (Memory Loop)
7.7.1.2 Post-Symptom Event Monitor
7.7.2 Event Monitors Market, By Technology
7.7.2.1 Autodetect Monitors
7.7.2.2 Manual Event Monitor
7.8 Mobile Cardiac Telemetry Monitoring (MCT/MCOT)
7.9 Smart Wearable ECG Monitors
8 Cardiac Monitoring Market: By Product
8.1 Introduction
8.2 Defibrillators
8.2.1 Implantable Cardioverter Defibrillators
8.2.1.1 Transvenous Implantable Cardioverter Defibrillators
8.2.1.1.1 Biventricular ICDS/Cardiac Resynchronization Therapy Defibrillators
8.2.1.1.2 Dual-Chamber ICDS
8.2.1.1.3 Single-Chamber ICDS
8.2.1.2 Subcutaneous Implantable Cardioverter Defibrillators
8.2.2 External Defibrillators
8.2.2.1 Automated External Defibrillators
8.2.2.1.1 Fully Automated External Defibrillators
8.2.2.1.2 Semi-Automated External Defibrillators
8.2.2.2 Manual External Defibrillators
8.2.2.3 Wearable Cardioverter Defibrillators
8.3 Pacemakers
8.3.1 Pacemakers Market, By Implantability
8.3.1.1 Implantable Pacemakers
8.3.1.2 External Pacemakers
8.3.2 Pacemakers Market, By Type
8.3.2.1 Dual-Chamber Pacemakers
8.3.2.2 Single-Chamber Pacemakers
9 Cardiac Monitoring and Cardiac Rhythm Management Devices Market, By End User
9.1 Introduction
9.2 Hospitals
9.3 Home and Ambulatory Care Settings
9.4 Other End Users
10 Cardiac Monitoring and Cardiac Rhythm Management Market, By Region
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 UK
10.3.4 Italy
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Rest of Asia (RoA)
10.5 Rest of the World
11 Cardiac Monitoring Market: Competitive Landscape
11.1 Introduction
11.2 Competitive Situation and Trends
11.2.1 Product Launches and Approvals
11.2.2 Agreements, Partnerships, and Contracts
11.2.3 Mergers and Acquisitions
11.2.4 Expansions
12 Company Profiles
12.1 Medtronic
12.2 Abbott
12.3 Boston Scientific
12.4 GE Healthcare
12.5 Philips Healthcare
12.6 Biotronik
12.7 Cardiac Science (A Portfolio Company of the Aurora Capital Group)
12.8 Livanova
12.9 Hill-Rom Holdings
12.10 Schiller
12.11 Biotelemetry
12.12 Applied Cardiac System
Chapter 13 Research Finding and Conclusion
Chapter 14 Research Methodology
Chapter 15 Research Data Source
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics